Physician profile
Kyle Boren
NPI 1619256328
$2,082.26
in general payments reported to CMS, 2019-2025
9 companies · $15.87 in 2025
The $15.87 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,769 · 2020: $18.29 · 2021: $148 · 2023: $39.63 · 2024: $91.53 · 2025: $15.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,751.43 | 2019-2024 | Mako |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.05 | 2019 | |
| Pacira Therapeutics, INC. | $67.89 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $63.09 | 2019-2021 | |
| Endo USA, INC. | $49.93 | 2024-2025 | Xiaflex |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $27.17 | 2024 | |
| Fidia Pharma USA INC. | $21.13 | 2023 | Hyalgan |
| Avanos Medical | $18.50 | 2023 | Trivisc Sodium Hyaluronate |
| Convatec INC. | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Boren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.